Dr. Armistead is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27599Phone+1 919-966-4131
Summary
- Stem cell transplant and cellular therapy
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2005 - 2008
- Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2005
- University of North Carolina at Chapel Hill School of MedicineClass of 2002
Certifications & Licensure
- NC State Medical License 2008 - 2025
- TX State Medical License 2005 - 2010
- MA State Medical License 2004 - 2005
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients Start of enrollment: 2018 Mar 01
Publications & Presentations
PubMed
- 39 citationsKilling tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses.Menglin Wang, Benoit Rousseau, Kunyu Qiu, Guannan Huang, Yu Zhang
Nature Biotechnology. 2024-08-01 - 36 citationsUtility of a safety switch to abrogate CD19.CAR T-cell–associated neurotoxicityMatthew C. Foster, Barbara Savoldo, Winnie W. Y. Lau, Clio Rubinos, Natalie S Grover
Blood. 2021-06-10 - 6 citationsEvaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients.Jing Zhu, Olivia Campagne, Chad Torrice, Gabrielle Flynn, Jordan A Miller
Clinical and Translational Science. 2021-05-01
Press Mentions
- Could Baking Soda Fight Leukemia Relapse After Stem Cell Transplant?January 5th, 2021
- UNC Lineberger Awards $1.35M for Cancer ResearchFebruary 11th, 2019
- Researchers Lay the Foundation for Personalized Immune Treatments for LeukemiaAugust 31st, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: